Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/22/2012EP2011508B1 Use of trap protein per se as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection
08/22/2012EP1774001B1 Mammalian Tissue Factor obtained from plants and applications of the same
08/22/2012EP1715042B1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
08/22/2012EP1694370B1 Wound care products containing keratin
08/22/2012EP1646397B1 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES
08/22/2012EP1644021B1 Methods and compositions for the treatment of gastrointestinal disorders
08/22/2012EP1584623B1 A group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof
08/22/2012EP1539225B1 Apparatus and methods for use in enzymatic escharotomy in burn induced compartment syndrome
08/22/2012EP1511764B1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2alpha receptor
08/22/2012EP1487426B1 Methods of inducing terminal differentiation
08/22/2012CN1909918B T cell immunoreaction inhibitor
08/22/2012CN1871023B A teicoplanin composition with improved antibiotic activity
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
08/22/2012CN102648212A Von willebrand factor (vWF)-containing preparations, and methods, kits, and uses related thereto
08/22/2012CN102648208A Tubulin inhibitors
08/22/2012CN102647998A Protease Variants
08/22/2012CN102647997A Inhibiting bacterial infection and biofilm formation
08/22/2012CN102647996A Relaxin peptide synthesis
08/22/2012CN102647995A SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
08/22/2012CN102647994A Methods for preventing or treating metabolic syndrome
08/22/2012CN102647993A Safe desmopressin administration
08/22/2012CN102647990A Methods of attenuating the loss of functional status
08/22/2012CN102647979A Diketopiperazine microparticles with defined specific surface areas
08/22/2012CN102643889A Antihypertensive active rapeseed peptide and preparation method and application thereof
08/22/2012CN102643762A Brevibacillus parabrevis as well as method and application of protein series prepared thereby
08/22/2012CN102643346A Novel antibiotic containing antibody simulant as well as preparation method and application for same
08/22/2012CN102643342A Tegillarca granosa hemoglobin Tg-HbIIA and application thereof
08/22/2012CN102643340A Novel polypeptide based on human TLR9 receptor functional domain segment LRR11 and application thereof
08/22/2012CN102643339A GLP-1 analogs, preparation method thereof application thereof
08/22/2012CN102643337A Polypeptides having antimicrobial activity and polynucleotides encoding same
08/22/2012CN102643333A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
08/22/2012CN102643327A Preparation method and application of polypeptide of fermented cucumber seeds
08/22/2012CN102641506A Bivalirudin-polyethylene glycol compound
08/22/2012CN102641497A Medicinal composition for treating gastrointestinal diseases
08/22/2012CN102641496A New application and composition of high-molecular polymer
08/22/2012CN102641495A Liver targeting interleukin-12/chitosan nano drug feeding system for intravenous injection and preparation method thereof
08/22/2012CN102641294A Preparation for treating ischemic cardio-vascular diseases and preparation method thereof
08/22/2012CN102641293A Preparation for treating ischemic cerebrovascular diseases and preparation method thereof
08/22/2012CN102334630B Composition containing oligopeptide and D-glucosamine hydrochloride for patients with bone injury
08/22/2012CN102178656B HM-3 polypeptide freeze-dried powder preparation and preparation method thereof
08/22/2012CN102058877B Pharmaceutical composition for osteoarthritis molding and preparation method thereof as well as molding method
08/22/2012CN102010460B Tea seed polypeptide and preparation method thereof
08/22/2012CN101802199B Promoterless cassettes for expression of alphavirus structural proteins
08/22/2012CN101766812B Liquid drug combination containing exenatide or analogues thereof
08/22/2012CN101629181B Preparation method of recombinant Fas-associated death domain protein and application thereof
08/22/2012CN101560246B Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
08/22/2012CN101544690B Vegetable proteins extracted from P.octandra, preparation method and application thereof
08/22/2012CN101500593B Methods for regulating inflammatory mediators and peptides useful therein
08/22/2012CN101384274B Compositions containing peptides with non-natural amino acids and methods of use
08/22/2012CN101310768B Medicine composition for treating hepatic disease and use thereof
08/22/2012CN101076349B Application of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
08/21/2012US8247613 Methods and compositions for the synergistic activation of latent HIV
08/21/2012US8247544 Method for producing a cell and/or tissue and/or disease phase specific medicament
08/21/2012US8247535 Directed evolution of GRG31 EPSP synthase enzyme
08/21/2012US8247534 Synthesis of radiofluorinated peptide using microwave activation technology
08/21/2012US8247532 Deuterated hepatitis C protease inhibitors
08/21/2012US8247531 Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor
08/21/2012US8247530 N-alkylated cyclic peptide melanocortin agonists
08/21/2012US8247529 Neoplasia targeting peptides and methods of using the same
08/21/2012US8247391 Macromolecules, lectins, dextrans, and/or concanavalin A moieties bind reversibly attached to crosslinked particles; sol-gel transformation; drug delivery
08/21/2012US8247381 Branched water-soluble polymers and their conjugates
08/21/2012US8247380 Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
08/21/2012US8247379 Tumor associated amino acids and uses therefor
08/21/2012US8247378 Homing peptide for tumor vasculature
08/21/2012US8247376 NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
08/21/2012US8247374 Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
08/21/2012US8247373 Lactoferrin compositions and methods of wound treatment
08/21/2012US8247372 Depsipeptides and their therapeutic use
08/21/2012US8247371 Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer
08/21/2012US8247370 Conjoint therapy for treating fibrotic diseases
08/21/2012US8247228 Method of inducing memory B cell development and terminal differentiation
08/21/2012US8247205 Chalcone isomerase polypeptides and crystals thereof
08/21/2012US8247190 Method for delivering cytotoxic activity to cells
08/21/2012US8247008 Digestive/laxative compositions
08/21/2012US8246991 Biocompatible and biodegradable elastomeric polymers
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012US8246960 Methods and compositions for generating bioactive assemblies of increased complexity and uses
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012US8246951 Collagenolytic active enzyme containing compositions, and their use in the dental field
08/21/2012US8246949 Methods and devices for sustained in-vivo release of an active agent
08/21/2012US8246540 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
08/21/2012CA2688047C Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration
08/21/2012CA2633413C Antibodies against tumor-associated antigenic target (tat) polypeptides
08/21/2012CA2579798C Interleukin-15 antagonist peptide
08/21/2012CA2569108C Angiogenesis-inhibiting chimeric protein and the use
08/21/2012CA2538842C A glycopeptide composition with improved antibiotic activity
08/21/2012CA2529179C Recombinant adeno-associated virus vector for treatment of alzheimer disease
08/21/2012CA2527024C Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
08/21/2012CA2522812C Hla-a2 tumor associated antigen peptides and compositions
08/21/2012CA2514090C Use of glutathione synthesis stimulating compounds in reducing insulin resistance
08/21/2012CA2485587C Muteins of placental growth factor type 1, preparation method and application thereof
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2459794C Vascular occlusion solid-phase agent with immobilised platelet binding agent
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/21/2012CA2445239C Drug delivery matrices to enhance wound healing
08/21/2012CA2412759C Injectable solution of an lhrh antagonist
08/21/2012CA2390129C Slimming composition containing a substance inducing il-6 production
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/21/2012CA2362830C Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
08/21/2012CA2348545C A complex of a chaperone with .beta.-amyloid and methods employing this complex
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 3163